BPSPrep

Syllabus

BCOP Prep Course (BCOP)

81 lessons. Online and self-paced.

Oncology Foundations

Core cancer biology, pathophysiology, resistance, testing concepts, and prevention principles that underpin exam-style oncology pharmacotherapy decisions.

  1. 1Carcinogenesis And Hallmarks
  2. 2Cancer Types And Kinetics
  3. 3Tumor Resistance Mechanisms
  4. 4Mutation Types And Amplification
  5. 5NGS And Assay Limits
  6. 6Predictive And Prognostic Tests
  7. 7Screening And Early Detection
  8. 8Risk Reduction Strategies
  9. 9Support And Education Resources

Treatment Planning

Foundational treatment-planning principles including staging context, lines of therapy, guidelines, survivorship, and patient-centered considerations within pharmacist scope.

  1. 10Curative And Palliative Intent
  2. 11Line Of Therapy Logic
  3. 12Guideline Concordant Regimen Support
  4. 13Performance Status And Frailty
  5. 14Social Determinants In Oncology
  6. 15Palliative Goals And End Of Life
  7. 16Survivorship Care Principles
  8. 17Nonmalignant Hematology Pharmacotherapy
  9. 18Transitional Care Coordination

Solid Tumor Therapeutics

High-yield disease-state pharmacotherapy for major solid tumors with emphasis on regimen selection support, biomarkers, sequencing, and pharmacist safety checks.

  1. 19Breast Cancer Regimen Frameworks
  2. 20Gynecologic Cancer Systemic Therapy
  3. 21Hormonal And Targeted Sequencing
  4. 22Lung Cancer Biomarker Therapy
  5. 23Colorectal And Hepatobiliary Regimens
  6. 24Upper GI And Pancreatic Therapy
  7. 25Genitourinary Cancer Regimens
  8. 26Melanoma And Skin Therapies
  9. 27CNS And Rare Tumors

Hematologic Malignancies

Major hematologic malignancy frameworks including leukemias, lymphomas, plasma cell disorders, and transplant or cellular therapy complications.

  1. 28AML And ALL Regimens
  2. 29CML And MPN Therapies
  3. 30CLL Treatment Sequencing
  4. 31Hodgkin And NHL Regimens
  5. 32Multiple Myeloma Pharmacotherapy
  6. 33Cellular Therapy Toxicities
  7. 34Conditioning And GVHD Prophylaxis
  8. 35Infection Prophylaxis Frameworks
  9. 36Transplant Complication Management

Antineoplastic Pharmacology

Mechanisms, PK/PD, class toxicities, administration nuances, and interaction principles across cytotoxic, targeted, hormonal, immune, and cellular therapies.

  1. 37Alkylators Antimetabolites Anthracyclines
  2. 38Taxanes Platinum And Topoisomerase
  3. 39Vinca And Specialty Agents
  4. 40Tyrosine Kinase Inhibitors
  5. 41Monoclonal And Antibody Conjugates
  6. 42Hormonal And Immune Pharmacology
  7. 43Dosage Forms And Routes
  8. 44Drug Food And Supplement Interactions
  9. 45Pharmacogenomic Relevance

Supportive Care

Essential supportive care for nausea, neutropenia, infection prevention, symptom management, and survivorship-oriented medication support.

  1. 46CINV Prophylaxis Frameworks
  2. 47Growth Factor Support Logic
  3. 48Anemia And Thrombocytopenia Support
  4. 49Febrile Neutropenia Management
  5. 50Tumor Lysis Prevention
  6. 51Mucositis Diarrhea And Nutrition
  7. 52Cancer Pain Pharmacotherapy
  8. 53Bone Health And Hypercalcemia
  9. 54End Of Life Symptom Support

Toxicities And Emergencies

Recognition, prevention, grading, and pharmacist-scope management of oncologic toxicities, emergencies, and long-term complications.

  1. 55Myelosuppression And Infection Risk
  2. 56Cardiac Pulmonary And Renal Injury
  3. 57Dermatologic Neurologic And Endocrine Effects
  4. 58Immune Related Adverse Events
  5. 59Infusion And Hypersensitivity Reactions
  6. 60Oncologic Emergency Pharmacotherapy
  7. 61Secondary Malignancies And Fertility
  8. 62Chronic Cardiometabolic And Bone Effects
  9. 63Long Term Monitoring Plans

Calculations Monitoring Safety

Dose calculations, organ function interpretation, regimen verification, hazardous drug handling, and pharmacist action frameworks for safe oncology practice.

  1. 64BSA Weight And AUC Dosing
  2. 65Renal And Hepatic Adjustments
  3. 66Exposure Limits And Cumulative Doses
  4. 67Pretreatment Parameter Review
  5. 68Response Assessment Principles
  6. 69Monitoring Plan Design
  7. 70Hazardous Drug Handling
  8. 71REMS Biosimilars And Access
  9. 72Quality And Error Prevention

Research And Evidence

Clinical trials, statistics, investigational drug management, and evidence interpretation for oncology pharmacists preparing for board-style questions.

  1. 73Study Designs And Validity
  2. 74Oncology Endpoints And Outcomes
  3. 75Drug Approval And Labeling
  4. 76Risk Measures And NNT
  5. 77P Values And Confidence Intervals
  6. 78Power Multiplicity And Subgroups
  7. 79Research Ethics And Consent
  8. 80IRB IEC And Trial Oversight
  9. 81Investigational Drug Management
Back to the program

Contact BPSPrep

Ask us about a program, enrollment or training for your team.

support@bpsprep.com
See the programs

BPSPrep
Programs
BPS Board Specialties 15
See all programs
For organizations
Team trainingPlans for training a whole team.Ask about group enrollmentTell us the programs and the size of your team.Email ussupport@bpsprep.com
ContactLog inGet a free guide